RVPH is within 8 weeks of reporting expected positive P3 results on a drug compound with blockbuster potential.
A great setup - Beautiful triangle formation is complete with a strong base. 200 day MA is easily within range.
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on RP5063 (Brilaroxazine) and...
RVPH, another possible short idea similar to CGC. Essentially, both charts present a H&S pattern; however, RVPH is not in a supply zone. This affects the strength of my thesis. In all honesty, I see this stock retracing to that 1.83 range I highlighted. No news as of today to justify the 68% rally. I'll be averaging around the current range, my average at the...
